New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss A new real-world study presented at the ASMBS 2025 Annual Meeting compares outcomes between GLP-1 medications (such as semaglutide and tirzepatide) and bariatric surgery
10.1016/S1474-4422(21)00061-2 147 WangY.XuH.FuQ.MaR.XiangJ
Ozempic and Wegovy are FDA-approved finished semaglutide products made by Novo Nordisk
They take time with you to explore the results you want and explain what they are doing
Participants also recorded reductions in waist circumference (average 7.1cm loss on 6mg, 8.2cm on 12mg, 10cm on 36mg, compared with 3.1cm loss on placebo), blood pressure (estimated -4.2 and -1mm HG difference between placebo and orforglipron in systolic and diatolic blood pressure, respectively) and cholesterol (-2.1% difference between placebo and orforglipron)
Morgan Wealth ManagementGarden CityNew York - Long Island (High Net Worth)$750K$701M$3-10M$1-10MRobert VotrubaNational Financial Network | Park Avenue SecuritiesGarden CityNew York - Long Island (High Net Worth)$1M$739M$2-15M$500K-10MJeffrey D